136 related articles for article (PubMed ID: 32890907)
1. CD105- and CD31-assessed microvessel density in laryngeal carcinoma biopsies as a predictor of recurrence after exclusive primary surgery.
Franz L; Alessandrini L; Saccardo T; Frigo AC; Marioni G
Ann Diagn Pathol; 2020 Oct; 48():151608. PubMed ID: 32890907
[TBL] [Abstract][Full Text] [Related]
2. Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens.
Alessandrini L; Ferrari M; Taboni S; Sbaraglia M; Franz L; Saccardo T; Del Forno BM; Agugiaro F; Frigo AC; Dei Tos AP; Marioni G
Oral Oncol; 2022 Sep; 132():105982. PubMed ID: 35759860
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma.
Marioni G; Franz L; Ottaviano G; Contro G; Tealdo G; Carli A; Frigo AC; Nicolai P; Alessandrini L
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722476
[TBL] [Abstract][Full Text] [Related]
4. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma.
Marioni G; Staffieri A; Manzato E; Ralli G; Lionello M; Giacomelli L; Prosenikliev V; Marchese-Ragona R; Busnardo A; Bolzetta F; Blandamura S
Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405
[TBL] [Abstract][Full Text] [Related]
5. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma.
Zvrko E; Mikic A; Vuckovic L
Auris Nasus Larynx; 2010 Feb; 37(1):77-83. PubMed ID: 19553039
[TBL] [Abstract][Full Text] [Related]
7. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma.
Zvrko E; Mikic A; Vuckovic L
Eur Arch Otorhinolaryngol; 2009 Dec; 266(12):1971-6. PubMed ID: 19340447
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
[TBL] [Abstract][Full Text] [Related]
9. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
10. Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases.
Mohamed SY; Mohammed HL; Ibrahim HM; Mohamed EM; Salah M
J Gastrointest Cancer; 2019 Mar; 50(1):23-34. PubMed ID: 29110224
[TBL] [Abstract][Full Text] [Related]
11. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.
Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A
Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Yao Y; Kubota T; Takeuchi H; Sato K
Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
[TBL] [Abstract][Full Text] [Related]
13. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
[TBL] [Abstract][Full Text] [Related]
14. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma.
Marioni G; Ottaviano G; Giacomelli L; Staffieri C; Casarotti-Todeschini S; Bonandini E; Staffieri A; Blandamura S
Eur J Surg Oncol; 2006 Dec; 32(10):1149-53. PubMed ID: 16979866
[TBL] [Abstract][Full Text] [Related]
15. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD105 but not of E-cadherin is associated with malignancy recurrence and disease-free interval in laryngeal cancer in men.
Zvrko E; Vuckovic L
Folia Histochem Cytobiol; 2023; 61(3):183-192. PubMed ID: 37787034
[TBL] [Abstract][Full Text] [Related]
17. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of angiogenesis-related factors: CD105, EphA2 and EphrinA1 in laryngeal squamous cell carcinoma and clinical implication].
Su J; Ji XB; Xie JH; Li W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):929-936. PubMed ID: 27978884
[No Abstract] [Full Text] [Related]
19. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
Martinović Ž; Kovač D; Martinović C
World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma].
Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
Przegl Lek; 2012; 69(10):726-30. PubMed ID: 23421020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
